“Bench to Clinic” web tool relaunched
Supporting the development of HIV vaccine candidates
Supporting the development of HIV vaccine candidates
In August 2012, the Global HIV Vaccine Enterprise began work on an interactive web tool to guide researchers, funders and advocates through the process of advancing their HIV vaccine candidates from preclinical studies to the first-in-human trials. The Enterprise engaged experts in manufacturing, regulatory, clinical, project management and other areas to gather the most critical information that would be useful to someone new to this transition process.
Over 15 experts provided the content, which was collated and organized by the Enterprise staff and external contributors. The content was reviewed to make the language and recommendations applicable internationally, including throughout the United States, Canada and the European Union. The resulting document was converted into an interactive web tool that allows not just easy navigation, but also selection of the type of candidate vaccine (DNA, protein or viral vector). The tool offers three confidence level scenarios (optimistic, average and pessimistic), which automatically adjust costs and timelines.
The Enterprise “Bench to Clinic” web tool was released on 1 October 2013. It provided an overview of the necessary steps in the process and estimates of corresponding timelines and budgets. It also drew attention to some potential challenges and provided links to relevant resources. A print version of the guide was created and made available for download. In 2015, the tool was reviewed and improved to include case studies and information specific to manufacturing in South Africa.
The Enterprise is now part of the International AIDS Society with a new strategy that emphasizes information sharing and supporting the development of HIV vaccine candidates. It is relaunching the “Bench to Clinic” web tool in the context of ongoing efficacy trials, a rich pipeline of new products and new approaches to the design and development of HIV vaccines. The tool remains valuable for understanding product development stages and processes and provides roadmaps that remain mostly unchanged. The Enterprise is committed to continue improving this tool and will seek input from scientific experts and manufacturing professionals.
The Global HIV Vaccine Enterprise (the Enterprise) unites stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of—and future access to—an HIV vaccine.
International AIDS Society
Avenue de France 23
CH-1202 Geneva
Switzerland
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OKLearn moreWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy policy